Posted in | News | Nanobusiness

NanoString Unveils Three Assay Kits for nCounter Analysis System

NanoString Technologies will introduce three new kits for the nCounter Analysis System, a completely automated, simple-workflow, multi-purpose digital detection and counting system, at the American Association of Cancer Research Annual Meeting to be conducted from March 31, to April 4, 2012, in Chicago, Illinois.

The three new products are the nCounter Plex2 Expression Assay Kit, the nCounter Cancer Copy Number Assay Kit, and the nCounter Human v2 miRNA Expression Assay Kit. These kits speed up sample output for validation studies, improve copy number analyses utilizing FFPE archival samples, and offer the most recent content for human microRNA assays.

The nCounter Plex2 Expression Assay Kit improves the nCounter system’s throughput four times by multiplexing in two dimensions utilizing barcodes, across both mRNA targets and samples. This assay kit enables nCounter users to analyze nearly 200 targets in four samples in just one tube, thus allowing more rapid validation analyses with a large number of samples to run in the nCounter system. At present, scientists can run 192 samples in a single day using the standard nCounter system and a maximum of 384 samples in a single day with the inclusion of a second prep station. The Plex2 kit offers specificity, sensitivity and FFPE compatibility equivalent to that of a standard assay of NanoString Technologies.

The nCounter Cancer Copy Number Assay Kit provides accurate analysis of 86 genes, which are usually deleted or amplified in several cancer types such as MYC, BRCA, PTEN, AKT, and PIK3CA. It is improved for FFPE sample analysis and is user-friendly like all other nCounter assays.

The nCounter Human v2 miRNA Expression Assay Kit is an upgraded version of NanoString’s proven miRNA expression kit but with content from miRBase 18. This kit enables researchers to profile 800 most highly expressed miRNAs in one tube and eliminates the necessity for amplification. NanoString Technologies’ nCounter miRNA panels provide better sensitivity and specificity at a reduced cost when compared to microarrays and next-generation sequencing.

Source: http://www.nanostring.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanostring Technologies. (2019, February 12). NanoString Unveils Three Assay Kits for nCounter Analysis System. AZoNano. Retrieved on February 22, 2024 from https://www.azonano.com/news.aspx?newsID=24597.

  • MLA

    Nanostring Technologies. "NanoString Unveils Three Assay Kits for nCounter Analysis System". AZoNano. 22 February 2024. <https://www.azonano.com/news.aspx?newsID=24597>.

  • Chicago

    Nanostring Technologies. "NanoString Unveils Three Assay Kits for nCounter Analysis System". AZoNano. https://www.azonano.com/news.aspx?newsID=24597. (accessed February 22, 2024).

  • Harvard

    Nanostring Technologies. 2019. NanoString Unveils Three Assay Kits for nCounter Analysis System. AZoNano, viewed 22 February 2024, https://www.azonano.com/news.aspx?newsID=24597.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.